Category Archives: Global Politics of IP

Public Hearing (Update) : 2016 Special 301 Report

Many of you may be wondering about my deafening silence on the 2016 Special 301 Report, which I’ve otherwise been aggressively pursuing. (For more on the Special 301, see my posts here, here, here and here). Unfortunately, even after a … Continue reading

Posted in Contemporary Legal Issues, Global Politics of IP, IP & Innovation Policy | 2 Comments

Public Hearing : 2016 Special 301 Report

“PhRMA wants USTR to ensure free reign to their greed while patients do not have any hope to have access.” Truth will out. The above statement from UACT’s  testimony to the 2016 Special 301 public hearing held on March 1, 2016 … Continue reading

Posted in Global Politics of IP, IP & Innovation Policy | 3 Comments

My Blog Post On India And The Special 301 Process

Last year when soliciting feedback on my blog,  my dear friend Pratik Sanwaria had asked me to cover the Special 301 Process. That time, I procrastinated his cogent suggestion even though the India – U.S IPR standoff is of immense … Continue reading

Posted in Global Politics of IP, IP & Innovation Policy | Leave a comment